KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Non Operating Income (2020 - 2023)

Historic Non Operating Income for AbCellera Biologics (ABCL) over the last 4 years, with Q4 2023 value amounting to $17.5 million.

  • AbCellera Biologics' Non Operating Income rose 17412.82% to $17.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $63.2 million, marking a year-over-year increase of 17970.07%. This contributed to the annual value of $114.4 million for FY2024, which is 8102.98% up from last year.
  • As of Q4 2023, AbCellera Biologics' Non Operating Income stood at $17.5 million, which was up 17412.82% from $15.6 million recorded in Q3 2023.
  • AbCellera Biologics' Non Operating Income's 5-year high stood at $17.5 million during Q4 2023, with a 5-year trough of -$13.5 million in Q4 2020.
  • Over the past 4 years, AbCellera Biologics' median Non Operating Income value was $5.4 million (recorded in 2021), while the average stood at $5.7 million.
  • In the last 5 years, AbCellera Biologics' Non Operating Income crashed by 6955.65% in 2022 and then skyrocketed by 78642.38% in 2023.
  • AbCellera Biologics' Non Operating Income (Quarter) stood at -$13.5 million in 2020, then soared by 123.43% to $3.2 million in 2021, then soared by 101.65% to $6.4 million in 2022, then surged by 174.13% to $17.5 million in 2023.
  • Its last three reported values are $17.5 million in Q4 2023, $15.6 million for Q3 2023, and $13.4 million during Q2 2023.